Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Cancers
|
March 13, 2024
Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation
Irene Dogliotti, Mario Levis, Aurora Martin, et al.
Journal of Hematology & Oncology
|
August 10, 2016
Ruxolitinib in steroid refractory graft-vs.-host disease: a case report
Enrico Maffini, Luisa Giaccone, Moreno Festuccia, et al.
The Journal of Antimicrobial Chemotherapy
|
June 3, 2026
Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patients
Pier Giorgio Cojutti, Alice Toschi, Zeno Pasquini, et al.
American Journal of Hematology
|
March 11, 2015
The use of ATG abrogates the antileukemic effect of cytomegalovirus reactivation in patients with acute myeloid leukemia receiving grafts from unrelated donors
Alessandro Busca, Roberto Passera, Massimo Pini, et al.
Cells
|
December 16, 2020
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model
Beatrice Anna Zannetti, Angelo Corso Faini, Evita Massari, et al.
Journal of Neurology
|
January 30, 2026
Prospective observational study of magnetic resonance imaging in anti-CD19 CAR T-cell-associated neurotoxicity
Gian Maria Asioli, Federica Pondrelli, Luca Spinardi, et al.
Haematologica
|
March 17, 2018
Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-<i>versus</i>-lymphoma effect
Enrico Maffini, Larry D Anderson, Brenda M Sandmaier, et al.
Transplantation and Cellular Therapy
|
February 16, 2023
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation
Gabriella Chirumbolo, Michele Dicataldo, Martina Barone, et al.
Frontiers in Oncology
|
December 19, 2022
The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
Enrico Maffini, Margherita Ursi, Francesco Barbato, et al.
British Journal of Haematology
|
December 19, 2023
Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost!
Gian Maria Asioli, Carlo Alberto Castioni, Pier Luigi Zinzani, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Cancers
|
March 13, 2024
Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation
Irene Dogliotti, Mario Levis, Aurora Martin, et al.
Journal of Hematology & Oncology
|
August 10, 2016
Ruxolitinib in steroid refractory graft-vs.-host disease: a case report
Enrico Maffini, Luisa Giaccone, Moreno Festuccia, et al.
The Journal of Antimicrobial Chemotherapy
|
June 3, 2026
Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patients
Pier Giorgio Cojutti, Alice Toschi, Zeno Pasquini, et al.
American Journal of Hematology
|
March 11, 2015
The use of ATG abrogates the antileukemic effect of cytomegalovirus reactivation in patients with acute myeloid leukemia receiving grafts from unrelated donors
Alessandro Busca, Roberto Passera, Massimo Pini, et al.
Cells
|
December 16, 2020
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model
Beatrice Anna Zannetti, Angelo Corso Faini, Evita Massari, et al.
Journal of Neurology
|
January 30, 2026
Prospective observational study of magnetic resonance imaging in anti-CD19 CAR T-cell-associated neurotoxicity
Gian Maria Asioli, Federica Pondrelli, Luca Spinardi, et al.
Haematologica
|
March 17, 2018
Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-<i>versus</i>-lymphoma effect
Enrico Maffini, Larry D Anderson, Brenda M Sandmaier, et al.
Transplantation and Cellular Therapy
|
February 16, 2023
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation
Gabriella Chirumbolo, Michele Dicataldo, Martina Barone, et al.
Frontiers in Oncology
|
December 19, 2022
The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
Enrico Maffini, Margherita Ursi, Francesco Barbato, et al.
British Journal of Haematology
|
December 19, 2023
Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost!
Gian Maria Asioli, Carlo Alberto Castioni, Pier Luigi Zinzani, et al.
Page
of 5